Technical challenges and quality considerations for dissolving microneedles.
Saved in:
| Title: | Technical challenges and quality considerations for dissolving microneedles. |
|---|---|
| Authors: | Kamal NS; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA. Electronic address: nahid.kamal@fda.hhs.gov., Acheampong S; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA., Zaman RU; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA., Strasinger C; Office of Pharmaceutical Quality Assessment II, OPQ, CDER, FDA, USA., Clark AG; digiM Solution 500 West Cummings Park, Woburn, MA 01801, USA., Zhu A; digiM Solution 500 West Cummings Park, Woburn, MA 01801, USA., Tang Y; Office of Pharmaceutical Quality Assessment III, OPQ, CDER, FDA, USA., Zidan A; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA., Ashraf M; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA. |
| Source: | International journal of pharmaceutics [Int J Pharm] 2026 May 05; Vol. 696, pp. 126830. Date of Electronic Publication: 2026 Mar 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
